What's breaking now, across thousands of outlets.
A reliable payout, a growing cancer treatment lineup, and improving guidance make this drugmaker worth a second look right now.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Multiple banks are now expecting a down leg for the tech trade, which could broaden out performance in a healthy way.
Multiple banks are now expecting a down leg for the tech trade, which could broaden out performance in a healthy way.
Taiwan Semiconductor's stock doesn't always react well to earnings reports.
ExxonMobil's 8.9% net margin outpaces Chevron's 6.7%, but Chevron's Guyana expansion could reshape the competitive landscape.
U.S. inflation accelerated last month as gas, clothes, and air fares got more expensive, evidence that rising prices remain an economic challenge just a few weeks before the midterm elections that…
Merchants can now accept digital asset payments on any phone or tablet and settle in the local currency to their bank account Launch supports the 90% of merchants who would accept crypto payments if…
